Posts |
What is Mounjaro—and how does it support weight loss?
The US Food and Drug Administration recently approved a new drug, Mounjaro (tirzepatide), as the first and only dual GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes.